COVID-19: Is It Wrong to Prioritize Younger Patients?

With the coronavirus pandemic increasing day by day, healthcare professionals are having to decide who should receive treatment, said experts.

COVID-19: With the coronavirus pandemic increasing day by day, healthcare professionals are having to decide who should receive treatment. Two experts debate the issue in The BMJ this week.

There are three reasons why age should not be used to decide who should and who should not receive potentially life saving treatment, argues Dave Archard, Emeritus Professor at Queen's University in Belfast.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘COVID-19: The relevance of old age as a predictive factor of efficacy, combined with the powerful principle of healthcare affording equality of opportunity to enjoy a life, makes age an important factor in making the terrible choice of who will receive scarce resources in a pandemic. ’

The first is that a simple "younger than" criterion is clearly unsatisfactory. It cannot be that an 18 year old is preferred to a 19 year old on the grounds of one year's difference in age. This would be not much better morally than tossing a coin or a crude "first come, first served" principle using the time of arrival at a hospital to determine whether care is given, he writes. Secondly, there is the fair innings argument. This holds that everyone should have an opportunity to lead a life of a certain duration. Resources should then be distributed (and care given selectively) to ensure that those who have yet to live that length of life are prioritized over those who have already managed to do so.

But while this has an intuitive appeal, there is no agreement on what counts as a fair innings. "Someone who has had her fair innings may yet have much to give the world that another who has not may be unable to offer," he says.

Finally, to discriminate between patients in the provision of care on the grounds of age is to send a message about the value of old people, he writes.

COVID-19 Virus Lab-Made, Nobel Winning Scientist
French Nobel prize winning scientist Luc Montagnier has sparked a fresh controversy by claiming that the SARS-CoV-2 virus came from a lab.

Such discrimination publicly expresses the view that older people are of lesser worth or importance than young people. "And it would be hard not to think-- even if it was not intended--that a cull of elderly people was what was being aimed at," he concludes.

But Arthur Caplan, Professor of Bioethics at NYU Grossman School of Medicine in New York, argues that age is a valid criterion when supported by data.

Biosensor For The COVID-19 Virus Discovered
Sensor that can quickly and reliably detect SARS-CoV-2 - the new coronavirus is the new focus.

He points out that age has played a role for many decades in limiting access to care when rationing life saving treatments, such as access to renal dialysis and organ transplants. That said, even in conditions of extreme scarcity "it would be discriminatory to simply invoke age to exclude those in need from services," he writes.

The key ethical question, he says, is whether age by itself is ever a morally relevant factor in deciding who gets care when rationing is unavoidable.

Checklist Developed For Safe Dialysis During And After COVID-19 Pandemic
Haemodialysis Unit Preparedness Checklist developed to deliver safe dialysis during and after COVID-19 pandemic.

Like Archard, he points to the notion of fair innings, but says this commitment to equality of opportunity has nothing to do with the relative contributions of old people versus young people. However, if the goal is to save the most lives with scarce resources then age may matter if there is a diminishing chance of survival with increased age, he adds.

"Ageism has no place in rationing, but age may."

Source-Eurekalert